Addex Therapeutics is a biopharmaceutical company focused on the development of novel, orally available, small molecule allosteric modulators for central nervous system disorders.

Sectors
Healthcare
Life Sciences
First Invested
2017
Public/PIPES
Company Status
IPO/Public
NASDAQ/SIX: ADXN
Associated Team
Paul Walker